Ginsenoside Rc ameliorated atherosclerosis via regulating gut microbiota and fecal metabolites
Atherosclerosis (AS) and the accompanied cardiovascular diseases (CVDs) were the leading cause of death worldwide. Recently, the association between CVDs, gut microbiota, and metabolites had aroused increasing attention. In the study, we headed our investigation into the underlying mechanism of gins...
Saved in:
Main Authors: | Bin Xie (Author), Xianpeng Zu (Author), Zhicong Wang (Author), Xike Xu (Author), Guoping Liu (Author), Runhui Liu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ginsenoside Rc Ameliorates Endothelial Insulin Resistance via Upregulation of Angiotensin-Converting Enzyme 2
by: Yaozhen Wang, et al.
Published: (2021) -
Ginsenoside Rc: A potential intervention agent for metabolic syndrome
by: Zhengjie Lu, et al.
Published: (2023) -
Fecal microbiota transplantation validates the importance of gut microbiota in an ApoE−/− mouse model of chronic apical periodontitis-induced atherosclerosis
by: Guowu Gan, et al.
Published: (2024) -
Gancao Xiexin Decoction Ameliorates Ulcerative Colitis in Mice via Modulating Gut Microbiota and Metabolites
by: Luo YT, et al.
Published: (2022) -
The Role of Gut Microbiota in Atherosclerosis and Hypertension
by: Junli Ma, et al.
Published: (2018)